Protein for Gastrointestinal complications for Therapeutic Agent

Researchers have identified a protein that targets the intestine lining maintenance cells as the primary cause of various chronic gastrointestinal complications that plague type 1 diabetes patients

Blocking that protein may be a way to reverse colon damage. About 80 percent of diabetes patients regularly experience gastroparesis abdominal distension irritable bowel syndrome and fecal incontinence.